These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26304919)

  • 41. A case of erythema nodosum leprosum reaction with diffuse alveolar haemorrhage, successfully treated by pulsed methylprednisolone.
    Nakwan N; Thaichinda S; Nakwan N
    Lepr Rev; 2010 Jun; 81(2):129-36. PubMed ID: 20825117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lucio's phenomenon/erythema necroticans.
    Sehgal VN
    Int J Dermatol; 2005 Jul; 44(7):602-5. PubMed ID: 15985035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 45. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of zafirlukast on leprosy reactions.
    Vides EA; Cabrera A; Ahern KP; Levis WR
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633
    [No Abstract]   [Full Text] [Related]  

  • 47. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
    J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of genitofemoral nerve with genital lesions in lepromatous leprosy.
    Agrawal SK; Singal A; Pandhi D; Oberoi S
    Indian J Lepr; 2004; 76(1):71-7. PubMed ID: 15527060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
    Benard G; Sakai-Valente NY; Bianconcini Trindade MA
    Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
    Saber M; Bourassa-Fulop C; Bouffard D; Provost N
    J Cutan Med Surg; 2010; 14(2):95-9. PubMed ID: 20338126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Necrotic erythema nodosum leprosum as the first manifestation of borderline lepromatous leprosy.
    Tourlaki A; Marzano AV; Gianotti R; Fiallo P; Nunzi E; Alessi E
    Arch Dermatol; 2008 Jun; 144(6):818-20. PubMed ID: 18559789
    [No Abstract]   [Full Text] [Related]  

  • 56. [Review: update on erythema nodosum leprosum].
    Morand JJ; Badiane C; Bobin P
    Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of erythema nodosum leprosum].
    Nguyen VU
    Ann Dermatol Venereol; 1994; 121(2):194-6. PubMed ID: 7979039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine in controlling type 2 reactions in leprosy: a case report.
    Athreya SP
    Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
    Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
    Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.